Lineage Cell Therapeutics, Inc. (LCTX)
1.03
-0.01
(-0.96%)
USD |
NYAM |
Oct 29, 16:00
Lineage Cell Therapeutics Market Cap : 260.49M for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 29, 2026 | 260.49M |
| October 28, 2026 | 263.02M |
| October 27, 2026 | 260.49M |
| October 26, 2026 | 252.12M |
| October 23, 2026 | 252.91M |
| October 22, 2026 | 249.11M |
| October 21, 2026 | 240.64M |
| October 20, 2026 | 245.98M |
| October 19, 2026 | 240.97M |
| October 16, 2026 | 247.42M |
| October 15, 2026 | 250.45M |
| October 14, 2026 | 232.04M |
| October 13, 2026 | 229.72M |
| October 12, 2026 | 241.30M |
| October 09, 2026 | 251.39M |
| October 08, 2026 | 260.49M |
| October 07, 2026 | 239.66M |
| October 06, 2026 | 237.20M |
| October 05, 2026 | 234.55M |
| October 02, 2026 | 235.28M |
| October 01, 2026 | 228.68M |
| September 30, 2026 | 241.70M |
| September 29, 2026 | 239.63M |
| September 28, 2026 | 245.57M |
| September 25, 2026 | 260.49M |
| Date | Value |
|---|---|
| September 24, 2026 | 239.71M |
| September 23, 2026 | 241.96M |
| September 22, 2026 | 263.02M |
| September 21, 2026 | 255.44M |
| September 18, 2026 | 260.49M |
| September 17, 2026 | 260.49M |
| September 16, 2026 | 270.61M |
| September 15, 2026 | 268.08M |
| September 14, 2026 | 270.61M |
| September 11, 2026 | 255.44M |
| September 10, 2026 | 257.97M |
| September 09, 2026 | 260.49M |
| September 08, 2026 | 275.67M |
| September 04, 2026 | 273.14M |
| September 03, 2026 | 278.20M |
| September 02, 2026 | 280.73M |
| September 01, 2026 | 273.14M |
| August 31, 2026 | 278.20M |
| August 28, 2026 | 280.73M |
| August 27, 2026 | 293.37M |
| August 26, 2026 | 283.26M |
| August 25, 2026 | 285.79M |
| August 24, 2026 | 275.67M |
| August 21, 2026 | 273.14M |
| August 20, 2026 | 273.14M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 301.29M |
| Amgen, Inc. | 256.48B |
| Anika Therapeutics, Inc. | 291.62M |
| BioCryst Pharmaceuticals, Inc. | 2.188B |
| Imunon, Inc. | 3.998M |
Market Cap Related Metrics
| PS Ratio | 19.58 |
| PEG Ratio | -6.003 |
| Price to Book Value | 4.276 |
| Price | 1.03 |
| Earnings Yield | -17.89% |
| PEGY Ratio | -6.003 |